Loss of p53 function through PAX‐mediated transcriptional repression.

E. T. Stuart(Max Planck Society), Rebecca Haffner(Max Planck Institute for Biophysical Chemistry), Moshe Oren(Max Planck Institute for Biophysical Chemistry), P. Gruss(Max Planck Society)
The EMBO Journal
November 1, 1995
10.1002/j.1460-2075.1995.tb00251.x
Cited by 237Open Access
Full Text

Abstract

Related Papers

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al.|PubMed|1994|2.2k
bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
Timothy J. McDonnell, Natasha G. Deane, Frances M. Platt et al.|Cell|1989|1.2k
Identification of a p53-dependent negative response element in the bcl-2 gene.
Toshiyuki Miyashita, Masayoshi Harigai, Masahito Hanada et al.|PubMed|1994|747
Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.
B Adams, Petra Dörfler, Adriano Aguzzi et al.|Genes & Development|1992|532
Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor.
Gregory R. Dressler, E C Douglass|Proceedings of the National Academy of Sciences|1992|414